PLoS ONE.Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Coverage Ebola (PLoS ONE.Designing and Testing Broadly-Protective Filoviral Vaccines Optimized for Cytotoxic T-Lymphocyte Epitope Cov…

more...

No comment yet.

Scooped by Gilbert C FAURE

September 26, 2012 3:07 AM

Scoop.it!

Immunology: Jump-starting cheaper cancer vaccines - A*STAR Research

From www.research.a-star.edu.sg - September 26, 2012 12:36 AM

A*STAR Research (Immunology: Jump-starting cheaper cancer vaccines: A technique to prime stem cells to induce anti-tumor immunity...)...

more...

No comment yet.

Scooped by Gilbert C FAURE

September 20, 2012 10:39 AM

Scoop.it!

Intercell announces Phase I results on its Vaccine Enhancement ...

From www.drugs.com - September 20, 2012 8:08 AM

The co-administration of an A H5N1 antigen via intramuscular administration (IM) with VEP met two of three CHMP criteria for Pandemic Influenza Vaccines, but th.

more...

No comment yet.

Scooped by Gilbert C FAURE

September 5, 2012 2:46 PM

Scoop.it!

Immunovative, Inc. Announces the Appointment of Members to the Scientific ... - Equities.com

From www.equities.com - September 4, 2012 10:37 AM

Immunovative, Inc. Announces the Appointment of Members to the Scientific ...Equities.comDr. Fong is a specialist in urologic oncology and an expert in tumor immunology and developing cancer vaccines.

more...

No comment yet.

Scooped by Gilbert C FAURE

August 21, 2012 2:26 PM

Scoop.it!

Immunological Mechanisms of Vaccination | The Immunologist

From theimmunologist.com - August 21, 2012 5:04 AM

A better understanding of the immunological mechanisms underpinning existing and novel vaccines is therefore required. Fortunately, research efforts to uncover new molecular and cellular techniques offer exceptional ...

more...

No comment yet.

Scooped by Gilbert C FAURE

September 28, 2012 1:54 AM

Scoop.it!

National Institutes of Health renews contract with La Jolla Institute to ... - La Jolla Light

From www.lajollalight.com - September 27, 2012 8:42 PM

National Institutes of Health renews contract with La Jolla Institute to ...La Jolla LightSuch information is vitally important to researchers attempting to design new and better vaccines against infectious diseases such as tuberculosis or treatments...

more...

No comment yet.

Scooped by Gilbert C FAURE

September 21, 2012 3:27 PM

Scoop.it!

Unraveling and understanding the roles of different bodies in the vaccines decision making - Centre de Conférences des Pensières Annecy - Veyrier du lac :

From www.congres-medical.com - September 21, 2012 3:27 PM

Unraveling and understanding the roles of different bodies in the vaccines decision making, Vaccinology is a relatively new field. It is a true meta-discipline which stands at the cross roads of epidemiology,
immunology, infectious diseases, ...

more...

No comment yet.

Scooped by Gilbert C FAURE

September 9, 2012 1:28 PM

Scoop.it!

Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline Market, Trends, Share, Size Research Report

From www.researchmoz.com - September 9, 2012 1:28 PM

Novel Therapies in Oncology - Protein Kinase Inhibitors, Monoclonal Antibodies and Vaccines Therapeutic Classes Dominate Late-Stage Pipeline Market Research Report Published in 2012-07-10 by GBI Research - GBI Research, the leading business...

more...

No comment yet.

Scooped by Gilbert C FAURE

August 30, 2012 3:34 PM

Scoop.it!

Designing bovine T cell vaccines via reverse immunology ...

From biolives.wordpress.com - August 30, 2012 9:19 AM

T cell responses contribute to immunity against many intracellular infections. There is, for example, strong evidence that major histocompatibility complex (MHC) class I-restricted cytotoxic T lymphocytes (CTLs) play an ...

more...

No comment yet.

Scooped by Gilbert C FAURE

July 31, 2012 4:27 AM

Scoop.it!

Paper highlights clinical and immunological activity of immatics' IMA901 in ... - News-Medical.net

From www.news-medical.net - July 30, 2012 12:00 AM

Paper highlights clinical and immunological activity of immatics' IMA901 in ...News-Medical.netimmatics biotechnologies GmbH, a clinical-stage biopharmaceutical company developing advanced therapeutic vaccines that are active against cancer, today...

more...

No comment yet.

About

Resources

Terms

Mobile

Features

Media Kit
Contact Scoop.it
Blog

	Facebook
	X
	LinkedIn

Resources Center
Plans
1 Introduction

Terms of Use
Privacy Policy
Copyright Policy
Manage cookies

Websites & blogs
Knowledge Sharing
Personal branding
Content distribution
Content hubs
Content API

How do I publish content on my topic?

Easy to do! You can:

choose from suggestions on the right-side panel
publish any web site on the fly in 1-click (bookmarklet)
copy paste a link in the input box below
rescoop other curators’ content

Learn More

Why should I brand my topic?

Branding your topics will give more credibility to your content, position you as a professional expert and generate conversions and leads.

Learn more

Well suggest content based on your keywords

Examples:

To get content containing either thought or leadership enter:

To get content containing both thought and leadership enter:

To get content containing the expression thought leadership enter:

You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.

Learn more

How do I follow my topics performance?

Measuring and analyzing your curation will help you to understand what your audience is looking for and how to improve your performance.

Learn more